DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway A Parrales, A Ranjan, SV Iyer, S Padhye, SJ Weir, A Roy, T Iwakuma Nature cell biology 18 (11), 1233-1243, 2016 | 211 | 2016 |
Radioprotective agents: strategies and translational advances MZ Kamran, A Ranjan, N Kaur, S Sur, V Tandon Medicinal research reviews 36 (3), 461-493, 2016 | 148 | 2016 |
Non-canonical cell death induced by p53 A Ranjan, T Iwakuma International journal of molecular sciences 17 (12), 2068, 2016 | 132 | 2016 |
MTBP inhibits migration and metastasis of hepatocellular carcinoma Q Bi, A Ranjan, R Fan, N Agarwal, DR Welch, SA Weinman, J Ding, ... Clinical & experimental metastasis 32, 301-311, 2015 | 50 | 2015 |
Genome-wide RNAi screening identifies TMIGD3 isoform1 as a suppressor of NF-κB and osteosarcoma progression SV Iyer, A Ranjan, HK Elias, A Parrales, H Sasaki, BC Roy, S Umar, ... Nature Communications 7 (1), 13561, 2016 | 33 | 2016 |
Inhibition of HIV-1 Integrase gene expression by 10-23 DNAzyme N Singh, A Ranjan, S Sur, R Chandra, V Tandon Journal of biosciences 37, 493-502, 2012 | 30 | 2012 |
DNAJA1 promotes cancer metastasis through interaction with mutant p53 A Kaida, S Yamamoto, A Parrales, ED Young, A Ranjan, MA Alalem, ... Oncogene 40 (31), 5013-5025, 2021 | 24 | 2021 |
MTBP inhibits the Erk1/2-Elk-1 signaling in hepatocellular carcinoma A Ranjan, SV Iyer, C Ward, T Link, FJ Diaz, A Dhar, OW Tawfik, ... Oncotarget 9 (30), 21429, 2018 | 19 | 2018 |
Akt1/NFκB signaling pathway activation by a small molecule DMA confers radioprotection to intestinal epithelium in xenograft model V Tiwari, MZ Kamran, A Ranjan, H Nimesh, M Singh, V Tandon Free Radical Biology and Medicine 108, 564-574, 2017 | 14 | 2017 |
Mutant p53 depletion by novel inhibitors for HSP40/J-domain proteins derived from the natural compound plumbagin M Alalem, M Bhosale, A Ranjan, S Yamamoto, A Kaida, S Nishikawa, ... Cancers 14 (17), 4187, 2022 | 12 | 2022 |
Unsaturated fatty acids regulate stemness of ovarian cancer cells through NF-κB A Parrales, A Ranjan, T Iwakuma Stem cell investigation 4, 2017 | 11 | 2017 |
Emerging non-canonical functions and regulation of p53 A Ranjan, T Iwakuma International journal of molecular sciences 19 (4), 1015, 2018 | 10 | 2018 |
Suppressive roles of A3AR and TMIGD3 i1 in osteosarcoma malignancy A Ranjan, SV Iyer, T Iwakuma Cell Cycle 16 (10), 903-904, 2017 | 9 | 2017 |
Inhibition of 5′-UTR RNA conformational switching in HIV-1 using antisense PNAs B Parkash, A Ranjan, V Tiwari, SK Gupta, N Kaur, V Tandon PLoS One 7 (11), e49310, 2012 | 9 | 2012 |
DNAJA1-and conformational mutant p53-dependent inhibition of cancer cell migration by a novel compound identified through a virtual screen S Nishikawa, A Kaida, A Parrales, A Ranjan, M Alalem, H Ren, ... Cell Death Discovery 8 (1), 437, 2022 | 8 | 2022 |
3, 4-Dimethoxyphenyl bis-benzimidazole derivative, mitigates radiation-induced DNA damage A Ranjan, N Kaur, V Tiwari, Y Singh, MM Chaturvedi, V Tandon Radiation research 179 (6), 647-662, 2013 | 8 | 2013 |
Murine double minute 2, a potential p53-independent regulator of liver cancer metastasis A Ranjan, K Bera, T Iwakuma | 7 | 2016 |
Identification of SFPQ as novel interacting partner of HIV-1 Integrase and its functional characterization S Sur, N Singh, N Kaur, A Ranjan, B Parkash, R Chandra, V Tandon BMC Infectious Diseases 12, 1-1, 2012 | 2 | 2012 |
DMA, a Bisbenzimidazole N Kaur, A Ranjan, V Tiwari, R Aneja, V Tandon Offers Radioprotec, 2012 | 1 | 2012 |
Abstract LB303: Suppression of stress granule formation is a novel vulnerability imposed by mutant p53 E Thoenen, A Ranjan, A Parrales, S Nishikawa, D Dixon, S Oka, ... Cancer Research 84 (7_Supplement), LB303-LB303, 2024 | | 2024 |